Rhythm Pharmaceuticals (RYTM) Insider Trading & Ownership → IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad) Free RYTM Stock Alerts $38.45 -0.07 (-0.18%) (As of 04/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$9.18 M Get RYTM Insider Trade Alerts Want to know when executives and insiders are buying or selling Rhythm Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RYTM Insider Buying and Selling by Quarter Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Rhythm Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/2/2024Christopher Paul GermanCAOSell368$41.76$15,367.68 3/21/2024Joseph ShulmanInsiderSell18,235$40.34$735,599.90 3/19/2024David P MeekerCEOSell45,494$39.22$1,784,274.68 3/19/2024Hunter C SmithCFOSell15,515$39.22$608,498.30 3/19/2024Yann MazabraudEVPSell16,000$39.22$627,520.00 2/14/2024Joseph ShulmanInsiderSell1,089$50.01$54,460.89 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/12/2024Hunter C SmithCFOSell1,209$51.38$62,118.42 2/12/2024Joseph ShulmanInsiderSell791$51.38$40,641.58 2/12/2024Yann MazabraudEVPSell1,594$51.38$81,899.72 2/9/2024Joseph ShulmanInsiderSell71,774$50.38$3,615,974.12 12/27/2023Joseph ShulmanInsiderSell5,015$50.01$250,800.15 12/5/2023Hunter C SmithCFOSell7,026$35.06$246,331.56 11/24/2023Hunter C SmithCFOSell10,974$35.02$384,309.48 11/8/2023Jennifer Kayden LeeEVPSell5,712$28.90$165,076.80 11/3/2023Jennifer Kayden LeeEVPSell80$28.00$2,240.00 9/5/2023Jennifer Kayden LeeEVPSell6,166$28.05$172,956.30 8/9/2023Jennifer Kayden LeeEVPSell1,718$24.66$42,365.88 8/7/2023Jennifer Kayden LeeEVPSell11,223$24.18$271,372.14 7/26/2023Pamela J CramerInsiderSell930$17.64$16,405.20 (Data available from 1/1/2013 forward) RYTM Insider Trading Activity - Frequently Asked Questions Who is on Rhythm Pharmaceuticals's Insider Roster? The list of insiders at Rhythm Pharmaceuticals includes Christopher Paul German, David P Meeker, Hunter C Smith, Jennifer Chien, Jennifer Kayden Lee, Joseph Shulman, Pamela J Cramer, William T Roberts, and Yann Mazabraud. Learn more on insiders at RYTM. What percentage of Rhythm Pharmaceuticals stock is owned by insiders? 4.70% of Rhythm Pharmaceuticals stock is owned by insiders. Learn more on RYTM's insider holdings. Which Rhythm Pharmaceuticals insiders have been selling company stock? The following insiders have sold RYTM shares in the last 24 months: Christopher Paul German ($15,367.68), David P Meeker ($1,784,274.68), Hunter C Smith ($1,389,580.94), Jennifer Chien ($50,033.17), Jennifer Kayden Lee ($654,011.12), Joseph Shulman ($4,712,362.62), Pamela J Cramer ($385,028.51), William T Roberts ($42,485.94), and Yann Mazabraud ($709,419.72). How much insider selling is happening at Rhythm Pharmaceuticals? Insiders have sold a total of 250,040 Rhythm Pharmaceuticals shares in the last 24 months for a total of $9,742,564.38 sold. More Insider Trading Tools from MarketBeat Related Companies: Corcept Therapeutics Insider Buying Arvinas Insider Buying Alpine Immune Sciences Insider Buying Merus Insider Buying Summit Therapeutics Insider Buying TG Therapeutics Insider Buying Keros Therapeutics Insider Buying Rocket Pharmaceuticals Insider Buying MoonLake Immunotherapeutics Insider Buying ACADIA Pharmaceuticals Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:RYTM) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldIRS Loophole Gives Americans An Escape From InflationBirch GoldHe Is Giving Away BitcoinCrypto Swap Profits[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.